Navigation Links
Centennial Taking Control of Your Diabetes Conference Returns to San Diego to Bring Answers, Advocacy and Hope
Date:11/7/2008

, who holds bodybuilding titles including Mr. USA and Mr. Universe, as well as 1999 Miss America winner and diabetes advocate Nicole Johnson. Mr. Burns and Ms. Johnson will share their personal stories, living well with type 1 diabetes.

Pre-registration is recommended and financial aid is available for those who need assistance. Early registration fees are $35 per person. Registration fees include lunch, healthy snacks, all conference activities and materials. FINANCIAL ASSISTANCE IS AVAILABLE BY CALLING TCOYD. Onsite registration begins at 7:30 a.m. and costs $40. The conference is from 8:30 a.m. to 5:00 p.m. To register or get more information, call 800-998-2693 or visit http://www.tcoyd.org.

Steven V. Edelman, MD, founder and director of Taking Control of Your Diabetes (TCOYD), was diagnosed with type 1 diabetes at the age of 15. Edelman, an internationally recognized leader in diabetes treatment, research and education, says, "It is my conviction that health care in this country will improve when the people living with diabetes themselves are informed and empowered to take an active role in their own condition."

Contact: Michele Huie

858-755-5683 / huie@tcoyd.org


'/>"/>
SOURCE Taking Control of Your Diabetes
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Emerging therapies with a focus on Asian populations mark the AACR Centennial Conference
2. Lions Taking to the Street Corners!
3. Philip Morris International Forced to Drop Another Concert Sponsorship; Philippines Health Department Applauded for Taking Action
4. Taking Codeine While Breast-Feeding May Harm Infant
5. AIDS Action Committee Applauds Legislature for Taking Action to Protect Patient Privacy Within New Electronic Medical Records System
6. Scientists race to stay ahead of the drug-taking and genetic manipulation that threatens sport
7. Taking Control: Future Therapies for a Host of Serious Diseases May Be Found in Womens Menstrual Blood
8. Taking care of business shouldnt be just for men
9. New Survey Reveals Hispanic-Americans Are Taking Steps to Better Understand and Manage GERD
10. Breathtaking New Campaign for Asthma Awareness Presents an Unsettling View of the Diseases Effects
11. Nearly 40 Percent of GERD Patients Taking PPIs Experience Recurring Symptoms
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)WASHINGTON, Dec. 4 The American Association of Homes and Services for the Aging (AAHSA) applauds the Senate for ensuring that the Community Living and Supportive Services (CLASS) provisions remain i
(Date:12/4/2009)MADISON HEIGHTS, Mich., Dec. 4 The Editorial Advisory and Securities Review Committee of BetterInvesting Magazine today announced Allergan, Inc. (NYSE: AGN ) as its February 2010 "Stock to Stud
(Date:12/4/2009)WASHINGTON, Dec. 4 In response to the U.S. Justice Department Drug Enforcement Agency,s (DEA) classification of boldione, desoxymethyltestosterone, and 19-nor-4,9(10)-androstadienedione as "anabolic
(Date:12/4/2009)Working with mice, scientists at Johns Hopkins publishing in the December issue of Neoplasia have shown that a protein made by a gene called "Twist" may be the proverbial red flag that can accuratel
(Date:12/4/2009)Rockville, MD "Why is it that men can be bastards and women must wear pearls and smile?" wrote author Lynn Hecht Schafran. The answer, according to an article in the Journal of Vision , may lie in
Breaking Medicine News(10 mins):Health News:BetterInvesting Magazine Releases February Stock to Study and Undervalued Stock Choicesfor Investors' Informational and Educational Use 2Health News:Natural Products Association Issues Statement on DEA's Steroid Classification Action 2Health News:Potential new 'twist' in breast cancer detection 2Health News:Potential new 'twist' in breast cancer detection 3Health News:Are angry women more like men? 2
... May 20 moksha8, Inc. announced today that it has...commercialize an additional portfolio of products ...on USD. , , moksha8 will commercialize products ..., Rocephin(R) and Bactrim(R). , , "moksha8 has ...
... Malchow Join Digirad Board of Directors , , POWA...DRAD ) today announced that it has named veteran h.... Malchow to its Board of Directors, effective imm...d business acumen that will make them immediate co...
...y Keeps the Doctor Away - Using QlikView, Inside I...ealth market trends such as tracking the progressi...tive profiling of disease trends. Essentially, Qli...9 -- The Australian health and pharmaceutical indu...
...growing personal injury law firms in Connecticut s...case management team that stays in frequent contac...n, Conn. (Lexis Nexis) May 20, 2009 -- Jonathan P... addition of two seasoned litigators to its team.,...
...Spinal Muscular Atrophy has just launched a new Me... MAC is one of the most highly respected bodies of...ting the agenda for proactive, creative, and colla...es, health care providers, and the public about SM...
...oint Call for Presidential Action on Cancer Policy...or and foundation director, will present a six-poi...ach to cancer prevention, screening, treatment and...ress Building, 529 14th St., N.W. , , (Logo: ht...
Other Medicine News:Health News:moksha8 Expands Alliance With Roche to Commercialize $200 Million of Products in Brazil and Mexico 2Health News:Digirad Names Two Veteran Healthcare Executives to Board 2Health News:Digirad Names Two Veteran Healthcare Executives to Board 3Health News:Digirad Names Two Veteran Healthcare Executives to Board 4Health News:Innovative Business Intelligence Software Helps Keep Australia Healthy this Winter 2Health News:Innovative Business Intelligence Software Helps Keep Australia Healthy this Winter 3Health News:Jonathan Perkins Injury Lawyers Adds Two Experienced Litigation Attorneys to Connecticut Team 2Health News:Families of Spinal Muscular Atrophy Announces its New Medical Advisory Council 2Health News:Families of Spinal Muscular Atrophy Announces its New Medical Advisory Council 3
(Date:12/3/2009)ALISO VIEJO, Calif. and STATE COLLEGE, Pa., Dec. 3 Ambry Genetics and SoftGenetics today announced the signing of an agreement to provide extended bioinformatics genomics services using SoftGenetics,
(Date:12/3/2009)SAN DIEGO, Dec. 3 BioMed Realty Trust, Inc. (NYSE: BMR ) announced today that it has entered into a new lease with Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN ) for approximately 131,000 square
(Date:12/3/2009)FORT WORTH, Texas, Dec. 3 Wound Management Technologies, Inc. (OTC Bulletin Board: WNDM), a rapidly growing provider of specialty medical products, announced today an agreement with the Health In
Breaking Medicine Technology:Ambry Genetics and SoftGenetics Form Exclusive Alliance for Extended Bioinformatics Support for Next Generation Sequencing Projects 2Ambry Genetics and SoftGenetics Form Exclusive Alliance for Extended Bioinformatics Support for Next Generation Sequencing Projects 3BioMed Realty Trust Signs New Lease With Regeneron Pharmaceuticals for 131,000 Square Feet at Landmark 2BioMed Realty Trust Signs New Lease With Regeneron Pharmaceuticals for 131,000 Square Feet at Landmark 3Wound Management Technologies, Inc. Signs Agreement with Major Sales Representative Organization for Increased Marketing of CellerateRx(R); Third Quarter Sales Up 2Wound Management Technologies, Inc. Signs Agreement with Major Sales Representative Organization for Increased Marketing of CellerateRx(R); Third Quarter Sales Up 3Prime Retail Launches Operation Shop Pink 56749 1Prime Retail Launches Operation Shop Pink 56749 2Champions Biotechnology and PinnacleCare Enter Into Personalized Oncology Collaboration Agreement 13976 1Champions Biotechnology and PinnacleCare Enter Into Personalized Oncology Collaboration Agreement 13976 2Champions Biotechnology and PinnacleCare Enter Into Personalized Oncology Collaboration Agreement 13976 3Champions Biotechnology and PinnacleCare Enter Into Personalized Oncology Collaboration Agreement 13976 4Mpex Pharmaceuticals Announces Positive Phase 2b Clinical Trial Results with Aeroquin 28R 29 28MP 376 29 Treatment in Cystic Fibrosis Patients 13973 1Mpex Pharmaceuticals Announces Positive Phase 2b Clinical Trial Results with Aeroquin 28R 29 28MP 376 29 Treatment in Cystic Fibrosis Patients 13973 2Mpex Pharmaceuticals Announces Positive Phase 2b Clinical Trial Results with Aeroquin 28R 29 28MP 376 29 Treatment in Cystic Fibrosis Patients 13973 3Mpex Pharmaceuticals Announces Positive Phase 2b Clinical Trial Results with Aeroquin 28R 29 28MP 376 29 Treatment in Cystic Fibrosis Patients 13973 4
...ll to be held on Wednesday, August 6, 2008 at 8:00...., Aug. 5 Isolagen(TM), Inc. (Amex:,ILE) announce...lts from two,pivotal, Phase III clinical studies (...rapy(TM) for the treatment of nasolabial folds, or...ial Protocol Assessment (SPA), met,all primary end...
... Nexgen Spine, a leading,developer of innovative ...nerative disc disease, announced today that it has...R) Lumbar Artificial Disc in the European,Union., ... Disc Prosthesis has,received CE mark approval," s...exgen Spine. "This represents an important milesto...
Other Medicine Technology:Isolagen, Inc. Reports Positive Top-line Results from Pivotal Phase III Studies of Isolagen Therapy(TM) in Wrinkles: Studies Meet All Primary Efficacy Endpoints and are Statistically Significant 2Isolagen, Inc. Reports Positive Top-line Results from Pivotal Phase III Studies of Isolagen Therapy(TM) in Wrinkles: Studies Meet All Primary Efficacy Endpoints and are Statistically Significant 3Isolagen, Inc. Reports Positive Top-line Results from Pivotal Phase III Studies of Isolagen Therapy(TM) in Wrinkles: Studies Meet All Primary Efficacy Endpoints and are Statistically Significant 4Isolagen, Inc. Reports Positive Top-line Results from Pivotal Phase III Studies of Isolagen Therapy(TM) in Wrinkles: Studies Meet All Primary Efficacy Endpoints and are Statistically Significant 5Nexgen Spine Receives CE Mark Approval for the Physio-L(R) Artificial Disc 2
...ty, comprehensive portable and bedside monitoring....o see up to four waveforms, including two vectors ...rough menus and is not impaired by gloves or tempe...els of ECG, heart/pulse rate, Smartcuf noninvasive...
...n allows emergency caregivers to establish an Emer...eded. Central Station monitoring can be deployed i...ions to increase the level and timeliness of care ...Welch Allyn's Propaq and Micropaq monitors, Mobile...
3775 Handheld Pulse Oximeter
... ,S/5 Clinical Communications is the newest gener... you and your care team to provide effective, high...ential patient information and be able to share it...of time and location. Clinical communication produ...
Medicine Products: